Medical Care
Global Cellular and Gene Therapy Product Market Research Report 2025
- Mar 11, 25
- ID: 20352
- Pages: 100
- Figures: 98
- Views: 1
The global market for Cellular and Gene Therapy Product was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cellular and Gene Therapy Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular and Gene Therapy Product.
The Cellular and Gene Therapy Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cellular and Gene Therapy Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular and Gene Therapy Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol-Myers Squibb
New York Blood Center
Johnson & Johnson
Cleveland Cord Blood Center
Organogenesis
Duke University School of Medicine
Colorado Cord Blood Banking
MD Anderson Cancer Center
LifeSouth Community Blood Centers
Bloodworks Northwest
Amgen
Novartis Pharmaceuticals
Castle Creek Biosciences
Spark Therapeutics
Vericel
Dendreon Pharmaceuticals
Enzyvant Therapeutics GmbH
Mallinckrodt
Gilead Sciences
bluebird bio
Segment by Type
Cellular Immunotherapies
Cancer Vaccines
Autologous and Allogeneic Cells
Segment by Application
Blood Cancer
Prostate Cancer
Skin Cancer
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cellular and Gene Therapy Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cellular and Gene Therapy Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cellular and Gene Therapy Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular and Gene Therapy Product.
The Cellular and Gene Therapy Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cellular and Gene Therapy Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular and Gene Therapy Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bristol-Myers Squibb
New York Blood Center
Johnson & Johnson
Cleveland Cord Blood Center
Organogenesis
Duke University School of Medicine
Colorado Cord Blood Banking
MD Anderson Cancer Center
LifeSouth Community Blood Centers
Bloodworks Northwest
Amgen
Novartis Pharmaceuticals
Castle Creek Biosciences
Spark Therapeutics
Vericel
Dendreon Pharmaceuticals
Enzyvant Therapeutics GmbH
Mallinckrodt
Gilead Sciences
bluebird bio
Segment by Type
Cellular Immunotherapies
Cancer Vaccines
Autologous and Allogeneic Cells
Segment by Application
Blood Cancer
Prostate Cancer
Skin Cancer
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cellular and Gene Therapy Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cellular and Gene Therapy Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Cellular and Gene Therapy Product Market Overview
1.1 Product Definition
1.2 Cellular and Gene Therapy Product by Type
1.2.1 Global Cellular and Gene Therapy Product Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cellular Immunotherapies
1.2.3 Cancer Vaccines
1.2.4 Autologous and Allogeneic Cells
1.3 Cellular and Gene Therapy Product by Application
1.3.1 Global Cellular and Gene Therapy Product Market Value by Application (2024 VS 2031)
1.3.2 Blood Cancer
1.3.3 Prostate Cancer
1.3.4 Skin Cancer
1.3.5 Other
1.4 Global Cellular and Gene Therapy Product Market Size Estimates and Forecasts
1.4.1 Global Cellular and Gene Therapy Product Revenue 2020-2031
1.4.2 Global Cellular and Gene Therapy Product Sales 2020-2031
1.4.3 Global Cellular and Gene Therapy Product Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cellular and Gene Therapy Product Market Competition by Manufacturers
2.1 Global Cellular and Gene Therapy Product Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cellular and Gene Therapy Product Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cellular and Gene Therapy Product Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cellular and Gene Therapy Product, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cellular and Gene Therapy Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cellular and Gene Therapy Product, Product Type & Application
2.7 Global Key Manufacturers of Cellular and Gene Therapy Product, Date of Enter into This Industry
2.8 Global Cellular and Gene Therapy Product Market Competitive Situation and Trends
2.8.1 Global Cellular and Gene Therapy Product Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cellular and Gene Therapy Product Players Market Share by Revenue
2.8.3 Global Cellular and Gene Therapy Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cellular and Gene Therapy Product Market Scenario by Region
3.1 Global Cellular and Gene Therapy Product Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cellular and Gene Therapy Product Sales by Region: 2020-2031
3.2.1 Global Cellular and Gene Therapy Product Sales by Region: 2020-2025
3.2.2 Global Cellular and Gene Therapy Product Sales by Region: 2026-2031
3.3 Global Cellular and Gene Therapy Product Revenue by Region: 2020-2031
3.3.1 Global Cellular and Gene Therapy Product Revenue by Region: 2020-2025
3.3.2 Global Cellular and Gene Therapy Product Revenue by Region: 2026-2031
3.4 North America Cellular and Gene Therapy Product Market Facts & Figures by Country
3.4.1 North America Cellular and Gene Therapy Product Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cellular and Gene Therapy Product Sales by Country (2020-2031)
3.4.3 North America Cellular and Gene Therapy Product Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cellular and Gene Therapy Product Market Facts & Figures by Country
3.5.1 Europe Cellular and Gene Therapy Product Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cellular and Gene Therapy Product Sales by Country (2020-2031)
3.5.3 Europe Cellular and Gene Therapy Product Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cellular and Gene Therapy Product Market Facts & Figures by Region
3.6.1 Asia Pacific Cellular and Gene Therapy Product Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cellular and Gene Therapy Product Sales by Region (2020-2031)
3.6.3 Asia Pacific Cellular and Gene Therapy Product Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cellular and Gene Therapy Product Market Facts & Figures by Country
3.7.1 Latin America Cellular and Gene Therapy Product Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cellular and Gene Therapy Product Sales by Country (2020-2031)
3.7.3 Latin America Cellular and Gene Therapy Product Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cellular and Gene Therapy Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Cellular and Gene Therapy Product Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cellular and Gene Therapy Product Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cellular and Gene Therapy Product Sales by Type (2020-2031)
4.1.1 Global Cellular and Gene Therapy Product Sales by Type (2020-2025)
4.1.2 Global Cellular and Gene Therapy Product Sales by Type (2026-2031)
4.1.3 Global Cellular and Gene Therapy Product Sales Market Share by Type (2020-2031)
4.2 Global Cellular and Gene Therapy Product Revenue by Type (2020-2031)
4.2.1 Global Cellular and Gene Therapy Product Revenue by Type (2020-2025)
4.2.2 Global Cellular and Gene Therapy Product Revenue by Type (2026-2031)
4.2.3 Global Cellular and Gene Therapy Product Revenue Market Share by Type (2020-2031)
4.3 Global Cellular and Gene Therapy Product Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cellular and Gene Therapy Product Sales by Application (2020-2031)
5.1.1 Global Cellular and Gene Therapy Product Sales by Application (2020-2025)
5.1.2 Global Cellular and Gene Therapy Product Sales by Application (2026-2031)
5.1.3 Global Cellular and Gene Therapy Product Sales Market Share by Application (2020-2031)
5.2 Global Cellular and Gene Therapy Product Revenue by Application (2020-2031)
5.2.1 Global Cellular and Gene Therapy Product Revenue by Application (2020-2025)
5.2.2 Global Cellular and Gene Therapy Product Revenue by Application (2026-2031)
5.2.3 Global Cellular and Gene Therapy Product Revenue Market Share by Application (2020-2031)
5.3 Global Cellular and Gene Therapy Product Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Company Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 New York Blood Center
6.2.1 New York Blood Center Company Information
6.2.2 New York Blood Center Description and Business Overview
6.2.3 New York Blood Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.2.4 New York Blood Center Cellular and Gene Therapy Product Product Portfolio
6.2.5 New York Blood Center Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Cellular and Gene Therapy Product Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Cleveland Cord Blood Center
6.4.1 Cleveland Cord Blood Center Company Information
6.4.2 Cleveland Cord Blood Center Description and Business Overview
6.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product Portfolio
6.4.5 Cleveland Cord Blood Center Recent Developments/Updates
6.5 Organogenesis
6.5.1 Organogenesis Company Information
6.5.2 Organogenesis Description and Business Overview
6.5.3 Organogenesis Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Organogenesis Cellular and Gene Therapy Product Product Portfolio
6.5.5 Organogenesis Recent Developments/Updates
6.6 Duke University School of Medicine
6.6.1 Duke University School of Medicine Company Information
6.6.2 Duke University School of Medicine Description and Business Overview
6.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Product Portfolio
6.6.5 Duke University School of Medicine Recent Developments/Updates
6.7 Colorado Cord Blood Banking
6.7.1 Colorado Cord Blood Banking Company Information
6.7.2 Colorado Cord Blood Banking Description and Business Overview
6.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product Portfolio
6.7.5 Colorado Cord Blood Banking Recent Developments/Updates
6.8 MD Anderson Cancer Center
6.8.1 MD Anderson Cancer Center Company Information
6.8.2 MD Anderson Cancer Center Description and Business Overview
6.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Product Portfolio
6.8.5 MD Anderson Cancer Center Recent Developments/Updates
6.9 LifeSouth Community Blood Centers
6.9.1 LifeSouth Community Blood Centers Company Information
6.9.2 LifeSouth Community Blood Centers Description and Business Overview
6.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product Portfolio
6.9.5 LifeSouth Community Blood Centers Recent Developments/Updates
6.10 Bloodworks Northwest
6.10.1 Bloodworks Northwest Company Information
6.10.2 Bloodworks Northwest Description and Business Overview
6.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Product Portfolio
6.10.5 Bloodworks Northwest Recent Developments/Updates
6.11 Amgen
6.11.1 Amgen Company Information
6.11.2 Amgen Description and Business Overview
6.11.3 Amgen Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Amgen Cellular and Gene Therapy Product Product Portfolio
6.11.5 Amgen Recent Developments/Updates
6.12 Novartis Pharmaceuticals
6.12.1 Novartis Pharmaceuticals Company Information
6.12.2 Novartis Pharmaceuticals Description and Business Overview
6.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product Portfolio
6.12.5 Novartis Pharmaceuticals Recent Developments/Updates
6.13 Castle Creek Biosciences
6.13.1 Castle Creek Biosciences Company Information
6.13.2 Castle Creek Biosciences Description and Business Overview
6.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Product Portfolio
6.13.5 Castle Creek Biosciences Recent Developments/Updates
6.14 Spark Therapeutics
6.14.1 Spark Therapeutics Company Information
6.14.2 Spark Therapeutics Description and Business Overview
6.14.3 Spark Therapeutics Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Spark Therapeutics Cellular and Gene Therapy Product Product Portfolio
6.14.5 Spark Therapeutics Recent Developments/Updates
6.15 Vericel
6.15.1 Vericel Company Information
6.15.2 Vericel Description and Business Overview
6.15.3 Vericel Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Vericel Cellular and Gene Therapy Product Product Portfolio
6.15.5 Vericel Recent Developments/Updates
6.16 Dendreon Pharmaceuticals
6.16.1 Dendreon Pharmaceuticals Company Information
6.16.2 Dendreon Pharmaceuticals Description and Business Overview
6.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product Portfolio
6.16.5 Dendreon Pharmaceuticals Recent Developments/Updates
6.17 Enzyvant Therapeutics GmbH
6.17.1 Enzyvant Therapeutics GmbH Company Information
6.17.2 Enzyvant Therapeutics GmbH Description and Business Overview
6.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product Portfolio
6.17.5 Enzyvant Therapeutics GmbH Recent Developments/Updates
6.18 Mallinckrodt
6.18.1 Mallinckrodt Company Information
6.18.2 Mallinckrodt Description and Business Overview
6.18.3 Mallinckrodt Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Mallinckrodt Cellular and Gene Therapy Product Product Portfolio
6.18.5 Mallinckrodt Recent Developments/Updates
6.19 Gilead Sciences
6.19.1 Gilead Sciences Company Information
6.19.2 Gilead Sciences Description and Business Overview
6.19.3 Gilead Sciences Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Gilead Sciences Cellular and Gene Therapy Product Product Portfolio
6.19.5 Gilead Sciences Recent Developments/Updates
6.20 bluebird bio
6.20.1 bluebird bio Company Information
6.20.2 bluebird bio Description and Business Overview
6.20.3 bluebird bio Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.20.4 bluebird bio Cellular and Gene Therapy Product Product Portfolio
6.20.5 bluebird bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cellular and Gene Therapy Product Industry Chain Analysis
7.2 Cellular and Gene Therapy Product Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cellular and Gene Therapy Product Production Mode & Process Analysis
7.4 Cellular and Gene Therapy Product Sales and Marketing
7.4.1 Cellular and Gene Therapy Product Sales Channels
7.4.2 Cellular and Gene Therapy Product Distributors
7.5 Cellular and Gene Therapy Product Customer Analysis
8 Cellular and Gene Therapy Product Market Dynamics
8.1 Cellular and Gene Therapy Product Industry Trends
8.2 Cellular and Gene Therapy Product Market Drivers
8.3 Cellular and Gene Therapy Product Market Challenges
8.4 Cellular and Gene Therapy Product Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Cellular and Gene Therapy Product by Type
1.2.1 Global Cellular and Gene Therapy Product Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cellular Immunotherapies
1.2.3 Cancer Vaccines
1.2.4 Autologous and Allogeneic Cells
1.3 Cellular and Gene Therapy Product by Application
1.3.1 Global Cellular and Gene Therapy Product Market Value by Application (2024 VS 2031)
1.3.2 Blood Cancer
1.3.3 Prostate Cancer
1.3.4 Skin Cancer
1.3.5 Other
1.4 Global Cellular and Gene Therapy Product Market Size Estimates and Forecasts
1.4.1 Global Cellular and Gene Therapy Product Revenue 2020-2031
1.4.2 Global Cellular and Gene Therapy Product Sales 2020-2031
1.4.3 Global Cellular and Gene Therapy Product Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cellular and Gene Therapy Product Market Competition by Manufacturers
2.1 Global Cellular and Gene Therapy Product Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cellular and Gene Therapy Product Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cellular and Gene Therapy Product Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cellular and Gene Therapy Product, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cellular and Gene Therapy Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cellular and Gene Therapy Product, Product Type & Application
2.7 Global Key Manufacturers of Cellular and Gene Therapy Product, Date of Enter into This Industry
2.8 Global Cellular and Gene Therapy Product Market Competitive Situation and Trends
2.8.1 Global Cellular and Gene Therapy Product Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cellular and Gene Therapy Product Players Market Share by Revenue
2.8.3 Global Cellular and Gene Therapy Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cellular and Gene Therapy Product Market Scenario by Region
3.1 Global Cellular and Gene Therapy Product Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cellular and Gene Therapy Product Sales by Region: 2020-2031
3.2.1 Global Cellular and Gene Therapy Product Sales by Region: 2020-2025
3.2.2 Global Cellular and Gene Therapy Product Sales by Region: 2026-2031
3.3 Global Cellular and Gene Therapy Product Revenue by Region: 2020-2031
3.3.1 Global Cellular and Gene Therapy Product Revenue by Region: 2020-2025
3.3.2 Global Cellular and Gene Therapy Product Revenue by Region: 2026-2031
3.4 North America Cellular and Gene Therapy Product Market Facts & Figures by Country
3.4.1 North America Cellular and Gene Therapy Product Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cellular and Gene Therapy Product Sales by Country (2020-2031)
3.4.3 North America Cellular and Gene Therapy Product Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cellular and Gene Therapy Product Market Facts & Figures by Country
3.5.1 Europe Cellular and Gene Therapy Product Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cellular and Gene Therapy Product Sales by Country (2020-2031)
3.5.3 Europe Cellular and Gene Therapy Product Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cellular and Gene Therapy Product Market Facts & Figures by Region
3.6.1 Asia Pacific Cellular and Gene Therapy Product Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cellular and Gene Therapy Product Sales by Region (2020-2031)
3.6.3 Asia Pacific Cellular and Gene Therapy Product Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cellular and Gene Therapy Product Market Facts & Figures by Country
3.7.1 Latin America Cellular and Gene Therapy Product Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cellular and Gene Therapy Product Sales by Country (2020-2031)
3.7.3 Latin America Cellular and Gene Therapy Product Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cellular and Gene Therapy Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Cellular and Gene Therapy Product Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cellular and Gene Therapy Product Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cellular and Gene Therapy Product Sales by Type (2020-2031)
4.1.1 Global Cellular and Gene Therapy Product Sales by Type (2020-2025)
4.1.2 Global Cellular and Gene Therapy Product Sales by Type (2026-2031)
4.1.3 Global Cellular and Gene Therapy Product Sales Market Share by Type (2020-2031)
4.2 Global Cellular and Gene Therapy Product Revenue by Type (2020-2031)
4.2.1 Global Cellular and Gene Therapy Product Revenue by Type (2020-2025)
4.2.2 Global Cellular and Gene Therapy Product Revenue by Type (2026-2031)
4.2.3 Global Cellular and Gene Therapy Product Revenue Market Share by Type (2020-2031)
4.3 Global Cellular and Gene Therapy Product Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cellular and Gene Therapy Product Sales by Application (2020-2031)
5.1.1 Global Cellular and Gene Therapy Product Sales by Application (2020-2025)
5.1.2 Global Cellular and Gene Therapy Product Sales by Application (2026-2031)
5.1.3 Global Cellular and Gene Therapy Product Sales Market Share by Application (2020-2031)
5.2 Global Cellular and Gene Therapy Product Revenue by Application (2020-2031)
5.2.1 Global Cellular and Gene Therapy Product Revenue by Application (2020-2025)
5.2.2 Global Cellular and Gene Therapy Product Revenue by Application (2026-2031)
5.2.3 Global Cellular and Gene Therapy Product Revenue Market Share by Application (2020-2031)
5.3 Global Cellular and Gene Therapy Product Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Company Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 New York Blood Center
6.2.1 New York Blood Center Company Information
6.2.2 New York Blood Center Description and Business Overview
6.2.3 New York Blood Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.2.4 New York Blood Center Cellular and Gene Therapy Product Product Portfolio
6.2.5 New York Blood Center Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Cellular and Gene Therapy Product Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Cleveland Cord Blood Center
6.4.1 Cleveland Cord Blood Center Company Information
6.4.2 Cleveland Cord Blood Center Description and Business Overview
6.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product Portfolio
6.4.5 Cleveland Cord Blood Center Recent Developments/Updates
6.5 Organogenesis
6.5.1 Organogenesis Company Information
6.5.2 Organogenesis Description and Business Overview
6.5.3 Organogenesis Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Organogenesis Cellular and Gene Therapy Product Product Portfolio
6.5.5 Organogenesis Recent Developments/Updates
6.6 Duke University School of Medicine
6.6.1 Duke University School of Medicine Company Information
6.6.2 Duke University School of Medicine Description and Business Overview
6.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Product Portfolio
6.6.5 Duke University School of Medicine Recent Developments/Updates
6.7 Colorado Cord Blood Banking
6.7.1 Colorado Cord Blood Banking Company Information
6.7.2 Colorado Cord Blood Banking Description and Business Overview
6.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product Portfolio
6.7.5 Colorado Cord Blood Banking Recent Developments/Updates
6.8 MD Anderson Cancer Center
6.8.1 MD Anderson Cancer Center Company Information
6.8.2 MD Anderson Cancer Center Description and Business Overview
6.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Product Portfolio
6.8.5 MD Anderson Cancer Center Recent Developments/Updates
6.9 LifeSouth Community Blood Centers
6.9.1 LifeSouth Community Blood Centers Company Information
6.9.2 LifeSouth Community Blood Centers Description and Business Overview
6.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product Portfolio
6.9.5 LifeSouth Community Blood Centers Recent Developments/Updates
6.10 Bloodworks Northwest
6.10.1 Bloodworks Northwest Company Information
6.10.2 Bloodworks Northwest Description and Business Overview
6.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Product Portfolio
6.10.5 Bloodworks Northwest Recent Developments/Updates
6.11 Amgen
6.11.1 Amgen Company Information
6.11.2 Amgen Description and Business Overview
6.11.3 Amgen Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Amgen Cellular and Gene Therapy Product Product Portfolio
6.11.5 Amgen Recent Developments/Updates
6.12 Novartis Pharmaceuticals
6.12.1 Novartis Pharmaceuticals Company Information
6.12.2 Novartis Pharmaceuticals Description and Business Overview
6.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product Portfolio
6.12.5 Novartis Pharmaceuticals Recent Developments/Updates
6.13 Castle Creek Biosciences
6.13.1 Castle Creek Biosciences Company Information
6.13.2 Castle Creek Biosciences Description and Business Overview
6.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Product Portfolio
6.13.5 Castle Creek Biosciences Recent Developments/Updates
6.14 Spark Therapeutics
6.14.1 Spark Therapeutics Company Information
6.14.2 Spark Therapeutics Description and Business Overview
6.14.3 Spark Therapeutics Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Spark Therapeutics Cellular and Gene Therapy Product Product Portfolio
6.14.5 Spark Therapeutics Recent Developments/Updates
6.15 Vericel
6.15.1 Vericel Company Information
6.15.2 Vericel Description and Business Overview
6.15.3 Vericel Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Vericel Cellular and Gene Therapy Product Product Portfolio
6.15.5 Vericel Recent Developments/Updates
6.16 Dendreon Pharmaceuticals
6.16.1 Dendreon Pharmaceuticals Company Information
6.16.2 Dendreon Pharmaceuticals Description and Business Overview
6.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product Portfolio
6.16.5 Dendreon Pharmaceuticals Recent Developments/Updates
6.17 Enzyvant Therapeutics GmbH
6.17.1 Enzyvant Therapeutics GmbH Company Information
6.17.2 Enzyvant Therapeutics GmbH Description and Business Overview
6.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product Portfolio
6.17.5 Enzyvant Therapeutics GmbH Recent Developments/Updates
6.18 Mallinckrodt
6.18.1 Mallinckrodt Company Information
6.18.2 Mallinckrodt Description and Business Overview
6.18.3 Mallinckrodt Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Mallinckrodt Cellular and Gene Therapy Product Product Portfolio
6.18.5 Mallinckrodt Recent Developments/Updates
6.19 Gilead Sciences
6.19.1 Gilead Sciences Company Information
6.19.2 Gilead Sciences Description and Business Overview
6.19.3 Gilead Sciences Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Gilead Sciences Cellular and Gene Therapy Product Product Portfolio
6.19.5 Gilead Sciences Recent Developments/Updates
6.20 bluebird bio
6.20.1 bluebird bio Company Information
6.20.2 bluebird bio Description and Business Overview
6.20.3 bluebird bio Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2020-2025)
6.20.4 bluebird bio Cellular and Gene Therapy Product Product Portfolio
6.20.5 bluebird bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cellular and Gene Therapy Product Industry Chain Analysis
7.2 Cellular and Gene Therapy Product Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cellular and Gene Therapy Product Production Mode & Process Analysis
7.4 Cellular and Gene Therapy Product Sales and Marketing
7.4.1 Cellular and Gene Therapy Product Sales Channels
7.4.2 Cellular and Gene Therapy Product Distributors
7.5 Cellular and Gene Therapy Product Customer Analysis
8 Cellular and Gene Therapy Product Market Dynamics
8.1 Cellular and Gene Therapy Product Industry Trends
8.2 Cellular and Gene Therapy Product Market Drivers
8.3 Cellular and Gene Therapy Product Market Challenges
8.4 Cellular and Gene Therapy Product Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Cellular and Gene Therapy Product Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cellular and Gene Therapy Product Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cellular and Gene Therapy Product Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cellular and Gene Therapy Product Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Cellular and Gene Therapy Product Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cellular and Gene Therapy Product Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cellular and Gene Therapy Product Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cellular and Gene Therapy Product, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cellular and Gene Therapy Product, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cellular and Gene Therapy Product, Product Type & Application
Table 12. Global Key Manufacturers of Cellular and Gene Therapy Product, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cellular and Gene Therapy Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy Product as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cellular and Gene Therapy Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cellular and Gene Therapy Product Sales by Region (2020-2025) & (K Units)
Table 18. Global Cellular and Gene Therapy Product Sales Market Share by Region (2020-2025)
Table 19. Global Cellular and Gene Therapy Product Sales by Region (2026-2031) & (K Units)
Table 20. Global Cellular and Gene Therapy Product Sales Market Share by Region (2026-2031)
Table 21. Global Cellular and Gene Therapy Product Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cellular and Gene Therapy Product Revenue Market Share by Region (2020-2025)
Table 23. Global Cellular and Gene Therapy Product Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cellular and Gene Therapy Product Revenue Market Share by Region (2026-2031)
Table 25. North America Cellular and Gene Therapy Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cellular and Gene Therapy Product Sales by Country (2020-2025) & (K Units)
Table 27. North America Cellular and Gene Therapy Product Sales by Country (2026-2031) & (K Units)
Table 28. North America Cellular and Gene Therapy Product Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cellular and Gene Therapy Product Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cellular and Gene Therapy Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cellular and Gene Therapy Product Sales by Country (2020-2025) & (K Units)
Table 32. Europe Cellular and Gene Therapy Product Sales by Country (2026-2031) & (K Units)
Table 33. Europe Cellular and Gene Therapy Product Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cellular and Gene Therapy Product Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cellular and Gene Therapy Product Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cellular and Gene Therapy Product Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Cellular and Gene Therapy Product Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Cellular and Gene Therapy Product Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cellular and Gene Therapy Product Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cellular and Gene Therapy Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cellular and Gene Therapy Product Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Cellular and Gene Therapy Product Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Cellular and Gene Therapy Product Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cellular and Gene Therapy Product Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cellular and Gene Therapy Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Cellular and Gene Therapy Product Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cellular and Gene Therapy Product Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cellular and Gene Therapy Product Sales (K Units) by Type (2020-2025)
Table 51. Global Cellular and Gene Therapy Product Sales (K Units) by Type (2026-2031)
Table 52. Global Cellular and Gene Therapy Product Sales Market Share by Type (2020-2025)
Table 53. Global Cellular and Gene Therapy Product Sales Market Share by Type (2026-2031)
Table 54. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cellular and Gene Therapy Product Revenue Market Share by Type (2020-2025)
Table 57. Global Cellular and Gene Therapy Product Revenue Market Share by Type (2026-2031)
Table 58. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2020-2025)
Table 59. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2026-2031)
Table 60. Global Cellular and Gene Therapy Product Sales (K Units) by Application (2020-2025)
Table 61. Global Cellular and Gene Therapy Product Sales (K Units) by Application (2026-2031)
Table 62. Global Cellular and Gene Therapy Product Sales Market Share by Application (2020-2025)
Table 63. Global Cellular and Gene Therapy Product Sales Market Share by Application (2026-2031)
Table 64. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cellular and Gene Therapy Product Revenue Market Share by Application (2020-2025)
Table 67. Global Cellular and Gene Therapy Product Revenue Market Share by Application (2026-2031)
Table 68. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2020-2025)
Table 69. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2026-2031)
Table 70. Bristol-Myers Squibb Company Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bristol-Myers Squibb Cellular and Gene Therapy Product Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. New York Blood Center Company Information
Table 76. New York Blood Center Description and Business Overview
Table 77. New York Blood Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. New York Blood Center Cellular and Gene Therapy Product Product
Table 79. New York Blood Center Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Johnson & Johnson Cellular and Gene Therapy Product Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Cleveland Cord Blood Center Company Information
Table 86. Cleveland Cord Blood Center Description and Business Overview
Table 87. Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product
Table 89. Cleveland Cord Blood Center Recent Developments/Updates
Table 90. Organogenesis Company Information
Table 91. Organogenesis Description and Business Overview
Table 92. Organogenesis Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Organogenesis Cellular and Gene Therapy Product Product
Table 94. Organogenesis Recent Developments/Updates
Table 95. Duke University School of Medicine Company Information
Table 96. Duke University School of Medicine Description and Business Overview
Table 97. Duke University School of Medicine Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Duke University School of Medicine Cellular and Gene Therapy Product Product
Table 99. Duke University School of Medicine Recent Developments/Updates
Table 100. Colorado Cord Blood Banking Company Information
Table 101. Colorado Cord Blood Banking Description and Business Overview
Table 102. Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product
Table 104. Colorado Cord Blood Banking Recent Developments/Updates
Table 105. MD Anderson Cancer Center Company Information
Table 106. MD Anderson Cancer Center Description and Business Overview
Table 107. MD Anderson Cancer Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. MD Anderson Cancer Center Cellular and Gene Therapy Product Product
Table 109. MD Anderson Cancer Center Recent Developments/Updates
Table 110. LifeSouth Community Blood Centers Company Information
Table 111. LifeSouth Community Blood Centers Description and Business Overview
Table 112. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product
Table 114. LifeSouth Community Blood Centers Recent Developments/Updates
Table 115. Bloodworks Northwest Company Information
Table 116. Bloodworks Northwest Description and Business Overview
Table 117. Bloodworks Northwest Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Bloodworks Northwest Cellular and Gene Therapy Product Product
Table 119. Bloodworks Northwest Recent Developments/Updates
Table 120. Amgen Company Information
Table 121. Amgen Description and Business Overview
Table 122. Amgen Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Amgen Cellular and Gene Therapy Product Product
Table 124. Amgen Recent Developments/Updates
Table 125. Novartis Pharmaceuticals Company Information
Table 126. Novartis Pharmaceuticals Description and Business Overview
Table 127. Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product
Table 129. Novartis Pharmaceuticals Recent Developments/Updates
Table 130. Castle Creek Biosciences Company Information
Table 131. Castle Creek Biosciences Description and Business Overview
Table 132. Castle Creek Biosciences Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Castle Creek Biosciences Cellular and Gene Therapy Product Product
Table 134. Castle Creek Biosciences Recent Developments/Updates
Table 135. Spark Therapeutics Company Information
Table 136. Spark Therapeutics Description and Business Overview
Table 137. Spark Therapeutics Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Spark Therapeutics Cellular and Gene Therapy Product Product
Table 139. Spark Therapeutics Recent Developments/Updates
Table 140. Vericel Company Information
Table 141. Vericel Description and Business Overview
Table 142. Vericel Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Vericel Cellular and Gene Therapy Product Product
Table 144. Vericel Recent Developments/Updates
Table 145. Dendreon Pharmaceuticals Company Information
Table 146. Dendreon Pharmaceuticals Description and Business Overview
Table 147. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product
Table 149. Dendreon Pharmaceuticals Recent Developments/Updates
Table 150. Enzyvant Therapeutics GmbH Company Information
Table 151. Enzyvant Therapeutics GmbH Description and Business Overview
Table 152. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product
Table 154. Enzyvant Therapeutics GmbH Recent Developments/Updates
Table 155. Mallinckrodt Company Information
Table 156. Mallinckrodt Description and Business Overview
Table 157. Mallinckrodt Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Mallinckrodt Cellular and Gene Therapy Product Product
Table 159. Mallinckrodt Recent Developments/Updates
Table 160. Gilead Sciences Company Information
Table 161. Gilead Sciences Description and Business Overview
Table 162. Gilead Sciences Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Gilead Sciences Cellular and Gene Therapy Product Product
Table 164. Gilead Sciences Recent Developments/Updates
Table 165. bluebird bio Company Information
Table 166. bluebird bio Description and Business Overview
Table 167. bluebird bio Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. bluebird bio Cellular and Gene Therapy Product Product
Table 169. bluebird bio Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Cellular and Gene Therapy Product Distributors List
Table 173. Cellular and Gene Therapy Product Customers List
Table 174. Cellular and Gene Therapy Product Market Trends
Table 175. Cellular and Gene Therapy Product Market Drivers
Table 176. Cellular and Gene Therapy Product Market Challenges
Table 177. Cellular and Gene Therapy Product Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cellular and Gene Therapy Product
Figure 2. Global Cellular and Gene Therapy Product Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cellular and Gene Therapy Product Market Share by Type: 2024 & 2031
Figure 4. Cellular Immunotherapies Product Picture
Figure 5. Cancer Vaccines Product Picture
Figure 6. Autologous and Allogeneic Cells Product Picture
Figure 7. Global Cellular and Gene Therapy Product Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Cellular and Gene Therapy Product Market Share by Application: 2024 & 2031
Figure 9. Blood Cancer
Figure 10. Prostate Cancer
Figure 11. Skin Cancer
Figure 12. Other
Figure 13. Global Cellular and Gene Therapy Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cellular and Gene Therapy Product Market Size (2020-2031) & (US$ Million)
Figure 15. Global Cellular and Gene Therapy Product Sales (2020-2031) & (K Units)
Figure 16. Global Cellular and Gene Therapy Product Average Price (US$/Unit) & (2020-2031)
Figure 17. Cellular and Gene Therapy Product Report Years Considered
Figure 18. Cellular and Gene Therapy Product Sales Share by Manufacturers in 2024
Figure 19. Global Cellular and Gene Therapy Product Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Cellular and Gene Therapy Product Players: Market Share by Revenue in Cellular and Gene Therapy Product in 2024
Figure 21. Cellular and Gene Therapy Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Cellular and Gene Therapy Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Cellular and Gene Therapy Product Sales Market Share by Country (2020-2031)
Figure 24. North America Cellular and Gene Therapy Product Revenue Market Share by Country (2020-2031)
Figure 25. United States Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Cellular and Gene Therapy Product Sales Market Share by Country (2020-2031)
Figure 28. Europe Cellular and Gene Therapy Product Revenue Market Share by Country (2020-2031)
Figure 29. Germany Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Cellular and Gene Therapy Product Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Cellular and Gene Therapy Product Revenue Market Share by Region (2020-2031)
Figure 36. China Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Cellular and Gene Therapy Product Sales Market Share by Country (2020-2031)
Figure 46. Latin America Cellular and Gene Therapy Product Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Cellular and Gene Therapy Product Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Cellular and Gene Therapy Product by Type (2020-2031)
Figure 56. Global Revenue Market Share of Cellular and Gene Therapy Product by Type (2020-2031)
Figure 57. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Cellular and Gene Therapy Product by Application (2020-2031)
Figure 59. Global Revenue Market Share of Cellular and Gene Therapy Product by Application (2020-2031)
Figure 60. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2020-2031)
Figure 61. Cellular and Gene Therapy Product Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Cellular and Gene Therapy Product Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cellular and Gene Therapy Product Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cellular and Gene Therapy Product Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cellular and Gene Therapy Product Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Cellular and Gene Therapy Product Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cellular and Gene Therapy Product Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cellular and Gene Therapy Product Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cellular and Gene Therapy Product, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cellular and Gene Therapy Product, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cellular and Gene Therapy Product, Product Type & Application
Table 12. Global Key Manufacturers of Cellular and Gene Therapy Product, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cellular and Gene Therapy Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy Product as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cellular and Gene Therapy Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cellular and Gene Therapy Product Sales by Region (2020-2025) & (K Units)
Table 18. Global Cellular and Gene Therapy Product Sales Market Share by Region (2020-2025)
Table 19. Global Cellular and Gene Therapy Product Sales by Region (2026-2031) & (K Units)
Table 20. Global Cellular and Gene Therapy Product Sales Market Share by Region (2026-2031)
Table 21. Global Cellular and Gene Therapy Product Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cellular and Gene Therapy Product Revenue Market Share by Region (2020-2025)
Table 23. Global Cellular and Gene Therapy Product Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cellular and Gene Therapy Product Revenue Market Share by Region (2026-2031)
Table 25. North America Cellular and Gene Therapy Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cellular and Gene Therapy Product Sales by Country (2020-2025) & (K Units)
Table 27. North America Cellular and Gene Therapy Product Sales by Country (2026-2031) & (K Units)
Table 28. North America Cellular and Gene Therapy Product Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cellular and Gene Therapy Product Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cellular and Gene Therapy Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cellular and Gene Therapy Product Sales by Country (2020-2025) & (K Units)
Table 32. Europe Cellular and Gene Therapy Product Sales by Country (2026-2031) & (K Units)
Table 33. Europe Cellular and Gene Therapy Product Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cellular and Gene Therapy Product Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cellular and Gene Therapy Product Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cellular and Gene Therapy Product Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Cellular and Gene Therapy Product Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Cellular and Gene Therapy Product Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cellular and Gene Therapy Product Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cellular and Gene Therapy Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cellular and Gene Therapy Product Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Cellular and Gene Therapy Product Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Cellular and Gene Therapy Product Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cellular and Gene Therapy Product Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cellular and Gene Therapy Product Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Cellular and Gene Therapy Product Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cellular and Gene Therapy Product Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cellular and Gene Therapy Product Sales (K Units) by Type (2020-2025)
Table 51. Global Cellular and Gene Therapy Product Sales (K Units) by Type (2026-2031)
Table 52. Global Cellular and Gene Therapy Product Sales Market Share by Type (2020-2025)
Table 53. Global Cellular and Gene Therapy Product Sales Market Share by Type (2026-2031)
Table 54. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cellular and Gene Therapy Product Revenue Market Share by Type (2020-2025)
Table 57. Global Cellular and Gene Therapy Product Revenue Market Share by Type (2026-2031)
Table 58. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2020-2025)
Table 59. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2026-2031)
Table 60. Global Cellular and Gene Therapy Product Sales (K Units) by Application (2020-2025)
Table 61. Global Cellular and Gene Therapy Product Sales (K Units) by Application (2026-2031)
Table 62. Global Cellular and Gene Therapy Product Sales Market Share by Application (2020-2025)
Table 63. Global Cellular and Gene Therapy Product Sales Market Share by Application (2026-2031)
Table 64. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cellular and Gene Therapy Product Revenue Market Share by Application (2020-2025)
Table 67. Global Cellular and Gene Therapy Product Revenue Market Share by Application (2026-2031)
Table 68. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2020-2025)
Table 69. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2026-2031)
Table 70. Bristol-Myers Squibb Company Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bristol-Myers Squibb Cellular and Gene Therapy Product Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. New York Blood Center Company Information
Table 76. New York Blood Center Description and Business Overview
Table 77. New York Blood Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. New York Blood Center Cellular and Gene Therapy Product Product
Table 79. New York Blood Center Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Johnson & Johnson Cellular and Gene Therapy Product Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Cleveland Cord Blood Center Company Information
Table 86. Cleveland Cord Blood Center Description and Business Overview
Table 87. Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product
Table 89. Cleveland Cord Blood Center Recent Developments/Updates
Table 90. Organogenesis Company Information
Table 91. Organogenesis Description and Business Overview
Table 92. Organogenesis Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Organogenesis Cellular and Gene Therapy Product Product
Table 94. Organogenesis Recent Developments/Updates
Table 95. Duke University School of Medicine Company Information
Table 96. Duke University School of Medicine Description and Business Overview
Table 97. Duke University School of Medicine Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Duke University School of Medicine Cellular and Gene Therapy Product Product
Table 99. Duke University School of Medicine Recent Developments/Updates
Table 100. Colorado Cord Blood Banking Company Information
Table 101. Colorado Cord Blood Banking Description and Business Overview
Table 102. Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product
Table 104. Colorado Cord Blood Banking Recent Developments/Updates
Table 105. MD Anderson Cancer Center Company Information
Table 106. MD Anderson Cancer Center Description and Business Overview
Table 107. MD Anderson Cancer Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. MD Anderson Cancer Center Cellular and Gene Therapy Product Product
Table 109. MD Anderson Cancer Center Recent Developments/Updates
Table 110. LifeSouth Community Blood Centers Company Information
Table 111. LifeSouth Community Blood Centers Description and Business Overview
Table 112. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product
Table 114. LifeSouth Community Blood Centers Recent Developments/Updates
Table 115. Bloodworks Northwest Company Information
Table 116. Bloodworks Northwest Description and Business Overview
Table 117. Bloodworks Northwest Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Bloodworks Northwest Cellular and Gene Therapy Product Product
Table 119. Bloodworks Northwest Recent Developments/Updates
Table 120. Amgen Company Information
Table 121. Amgen Description and Business Overview
Table 122. Amgen Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Amgen Cellular and Gene Therapy Product Product
Table 124. Amgen Recent Developments/Updates
Table 125. Novartis Pharmaceuticals Company Information
Table 126. Novartis Pharmaceuticals Description and Business Overview
Table 127. Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product
Table 129. Novartis Pharmaceuticals Recent Developments/Updates
Table 130. Castle Creek Biosciences Company Information
Table 131. Castle Creek Biosciences Description and Business Overview
Table 132. Castle Creek Biosciences Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Castle Creek Biosciences Cellular and Gene Therapy Product Product
Table 134. Castle Creek Biosciences Recent Developments/Updates
Table 135. Spark Therapeutics Company Information
Table 136. Spark Therapeutics Description and Business Overview
Table 137. Spark Therapeutics Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Spark Therapeutics Cellular and Gene Therapy Product Product
Table 139. Spark Therapeutics Recent Developments/Updates
Table 140. Vericel Company Information
Table 141. Vericel Description and Business Overview
Table 142. Vericel Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Vericel Cellular and Gene Therapy Product Product
Table 144. Vericel Recent Developments/Updates
Table 145. Dendreon Pharmaceuticals Company Information
Table 146. Dendreon Pharmaceuticals Description and Business Overview
Table 147. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product
Table 149. Dendreon Pharmaceuticals Recent Developments/Updates
Table 150. Enzyvant Therapeutics GmbH Company Information
Table 151. Enzyvant Therapeutics GmbH Description and Business Overview
Table 152. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product
Table 154. Enzyvant Therapeutics GmbH Recent Developments/Updates
Table 155. Mallinckrodt Company Information
Table 156. Mallinckrodt Description and Business Overview
Table 157. Mallinckrodt Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Mallinckrodt Cellular and Gene Therapy Product Product
Table 159. Mallinckrodt Recent Developments/Updates
Table 160. Gilead Sciences Company Information
Table 161. Gilead Sciences Description and Business Overview
Table 162. Gilead Sciences Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Gilead Sciences Cellular and Gene Therapy Product Product
Table 164. Gilead Sciences Recent Developments/Updates
Table 165. bluebird bio Company Information
Table 166. bluebird bio Description and Business Overview
Table 167. bluebird bio Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. bluebird bio Cellular and Gene Therapy Product Product
Table 169. bluebird bio Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Cellular and Gene Therapy Product Distributors List
Table 173. Cellular and Gene Therapy Product Customers List
Table 174. Cellular and Gene Therapy Product Market Trends
Table 175. Cellular and Gene Therapy Product Market Drivers
Table 176. Cellular and Gene Therapy Product Market Challenges
Table 177. Cellular and Gene Therapy Product Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cellular and Gene Therapy Product
Figure 2. Global Cellular and Gene Therapy Product Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cellular and Gene Therapy Product Market Share by Type: 2024 & 2031
Figure 4. Cellular Immunotherapies Product Picture
Figure 5. Cancer Vaccines Product Picture
Figure 6. Autologous and Allogeneic Cells Product Picture
Figure 7. Global Cellular and Gene Therapy Product Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Cellular and Gene Therapy Product Market Share by Application: 2024 & 2031
Figure 9. Blood Cancer
Figure 10. Prostate Cancer
Figure 11. Skin Cancer
Figure 12. Other
Figure 13. Global Cellular and Gene Therapy Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cellular and Gene Therapy Product Market Size (2020-2031) & (US$ Million)
Figure 15. Global Cellular and Gene Therapy Product Sales (2020-2031) & (K Units)
Figure 16. Global Cellular and Gene Therapy Product Average Price (US$/Unit) & (2020-2031)
Figure 17. Cellular and Gene Therapy Product Report Years Considered
Figure 18. Cellular and Gene Therapy Product Sales Share by Manufacturers in 2024
Figure 19. Global Cellular and Gene Therapy Product Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Cellular and Gene Therapy Product Players: Market Share by Revenue in Cellular and Gene Therapy Product in 2024
Figure 21. Cellular and Gene Therapy Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Cellular and Gene Therapy Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Cellular and Gene Therapy Product Sales Market Share by Country (2020-2031)
Figure 24. North America Cellular and Gene Therapy Product Revenue Market Share by Country (2020-2031)
Figure 25. United States Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Cellular and Gene Therapy Product Sales Market Share by Country (2020-2031)
Figure 28. Europe Cellular and Gene Therapy Product Revenue Market Share by Country (2020-2031)
Figure 29. Germany Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Cellular and Gene Therapy Product Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Cellular and Gene Therapy Product Revenue Market Share by Region (2020-2031)
Figure 36. China Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Cellular and Gene Therapy Product Sales Market Share by Country (2020-2031)
Figure 46. Latin America Cellular and Gene Therapy Product Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Cellular and Gene Therapy Product Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Cellular and Gene Therapy Product Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Cellular and Gene Therapy Product by Type (2020-2031)
Figure 56. Global Revenue Market Share of Cellular and Gene Therapy Product by Type (2020-2031)
Figure 57. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Cellular and Gene Therapy Product by Application (2020-2031)
Figure 59. Global Revenue Market Share of Cellular and Gene Therapy Product by Application (2020-2031)
Figure 60. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2020-2031)
Figure 61. Cellular and Gene Therapy Product Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232